BioXcel Therapeutics
BTAI
BTAI
36 hedge funds and large institutions have $32.6M invested in BioXcel Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.19% more ownership
Funds ownership: 1% → 1.2% (+0.19%)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.12M | |
| 2 | +$887K | |
| 3 | +$526K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$384K |
| 5 |
Squarepoint
New York
|
+$352K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$159K | |
| 3 | -$127K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.5K |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$1K |